Mittie Doyle - Mar 31, 2022 Form 4 Insider Report for DICE Therapeutics, Inc. (DICE)

Role
Director
Signature
/s/ Scott Robertson as attorney-in-fact for Mittie Doyle
Stock symbol
DICE
Transactions as of
Mar 31, 2022
Transactions value $
$0
Form type
4
Date filed
4/1/2022, 06:27 PM
Previous filing
Apr 1, 2022
Next filing
Aug 9, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DICE Stock Option (right to buy) Award $0 +42.5K $0.00 42.5K Mar 31, 2022 Common Stock 42.5K $19.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/36th of the total shares on each monthly anniversary of March 31, 2022, subject to the Reporting Holder's continued service to the Registrant.